Electromagnetic hypersensitivity (EHS) is a condition in which people experience real physical symptoms that they attribute to exposure to electromagnetic fields (EMFs) from devices like Wi-Fi routers, cell phones, power lines, and computer screens. It is not currently recognized as a medical diagnosis by the World Health Organization or included in the International Classification of Diseases. The symptoms people report are genuine and sometimes debilitating, but decades of controlled research have not found a causal link between EMF exposure and those symptoms.
Symptoms People Report
The symptoms associated with EHS are wide-ranging and nonspecific, meaning they overlap with many other conditions. The most commonly reported complaints fall into two categories. The first is skin-related: redness, tingling, and burning sensations, often on the face and hands. The second is neurological and systemic: fatigue, difficulty concentrating, dizziness, nausea, heart palpitations, and digestive problems.
Some people experience only mild discomfort near certain devices, while others describe symptoms severe enough to disrupt work, sleep, and social life. A small number of individuals have made significant lifestyle changes to avoid EMFs, including leaving jobs, moving to rural areas, or shielding their homes with specialized materials. The severity varies enormously from person to person, but the distress is consistent: people who identify as having EHS genuinely feel unwell.
What Controlled Studies Show
The central scientific question is straightforward: can people with EHS actually detect when EMFs are present? Researchers have tested this repeatedly using double-blind provocation studies, where participants are exposed to real EMF signals and fake (sham) signals without knowing which is which. The results have been remarkably consistent.
In one aggregated analysis of two double-blind base station provocation studies, participants who identified as EMF-sensitive reported feeling worse during real exposure in open trials, when they knew the signal was on. But during double-blind trials, when neither the participant nor the researcher knew whether the signal was active, that difference disappeared. People reported similar levels of discomfort regardless of whether the EMF was real or sham. This pattern has been replicated across many studies. People respond to the belief that they are being exposed, not to the exposure itself.
The international body that sets EMF safety limits, ICNIRP, updated its guidelines in 2020 after reviewing extensive research on health outcomes like headaches, concentration problems, sleep quality, and cardiovascular effects. The conclusion: no adverse health effects have been demonstrated at exposure levels below thermal thresholds (the point where EMFs would actually heat tissue). The only consistently observed finding is a small change in brain electrical activity measured by EEG, and its biological significance remains unclear.
The Nocebo Effect
The leading explanation for EHS symptoms involves the nocebo effect, which is essentially the opposite of a placebo. Where a placebo produces positive effects from an inactive treatment because you expect to feel better, a nocebo produces negative effects because you expect to feel worse. If you believe that a Wi-Fi router is harmful, your nervous system can generate real, measurable symptoms in response to that belief. This is not “faking it.” Nocebo responses involve genuine physiological changes, including stress hormone release, pain signaling, and inflammation.
Qualitative research on people with EHS suggests the nocebo mechanism may kick in at a specific stage of the condition’s development. Someone might initially experience unexplained symptoms, then encounter information linking those symptoms to EMFs (through media, online communities, or word of mouth), and then begin noticing a pattern that reinforces the belief. Once that attribution is established, the nocebo response can strengthen it further, creating a self-reinforcing cycle where proximity to devices reliably triggers discomfort.
Why It Is Not a Formal Diagnosis
EHS has no diagnostic code in the WHO’s International Classification of Diseases (ICD), and it does not appear in any major diagnostic manual. This is not because the symptoms are dismissed as imaginary. Rather, the term describes a collection of symptoms attributed to a specific cause (EMFs), and the evidence does not support that cause. Without a demonstrable mechanism linking EMF exposure to the reported symptoms, there is no basis for a standalone diagnosis.
The WHO’s position is that treatment should focus on the symptoms themselves rather than on reducing EMF exposure, since the symptoms may be driven by anxiety about EMFs, pre-existing conditions, or other environmental factors. This puts people who identify as having EHS in a difficult position. They feel genuinely ill, yet the medical system has no formal category for their experience. Researchers have described this as a kind of “medical limbo.”
Legal Recognition in Some Countries
Despite the lack of a medical diagnosis, some countries have taken steps to accommodate people with EHS. Sweden is the most notable example, where electrohypersensitivity is officially recognized as a functional impairment. This is an important distinction: it is classified as an impairment, not a disease. That means Swedish authorities acknowledge the condition affects a person’s ability to function in daily life and may entitle them to workplace accommodations or other support, without making a claim about what causes it. Few other countries have followed Sweden’s approach, and recognition varies widely around the world.
Managing EHS Symptoms
Because the symptoms are real even if the attributed cause is not supported by evidence, management focuses on treating what the person actually experiences. Cognitive behavioral therapy (CBT) has shown promise in helping people re-examine the connection they draw between EMF exposure and their symptoms, gradually reducing the anxiety and anticipatory stress that may fuel the nocebo cycle. Addressing sleep problems, stress, and any underlying conditions (such as anxiety disorders, migraines, or chronic fatigue) often improves symptoms significantly.
Some people pursue EMF-avoidance strategies like shielding rooms, turning off Wi-Fi at night, or using wired connections. While these measures are unlikely to cause harm, the WHO’s concern is that focusing exclusively on EMF reduction can reinforce the belief that drives the symptoms and delay treatment for other conditions that may be responsible. A thorough medical evaluation to rule out other causes of fatigue, skin symptoms, and neurological complaints is an important first step, since many of the symptoms attributed to EHS are also hallmarks of conditions that respond well to treatment.